Hypoalbuminemia Clinical Trial
— STEWALBOfficial title:
Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach
Verified date | November 2014 |
Source | University Hospital, Clermont-Ferrand |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Observational |
The primary purpose was to describe the acid base balance of ICU patients with severe hypoalbuminemia using Stewart's approach for acid base disorders, before and after an human albumin perfusion.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | November 2014 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - serum albuminemia < 20g/L - adult ICU patient - Arterial line Exclusion Criteria: - albumin allergy - pregnancy - congestive heart failure |
Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
France | CHU de Clermont-Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | changes in pH and independent pH determinants using Stewart approach | at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. | No | |
Secondary | changes in neurologic parameters | at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. | No | |
Secondary | changes in hemodynamic parameters | at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. | No | |
Secondary | changes in respiratory parameters | at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05050851 -
Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt
|
||
Terminated |
NCT00529633 -
The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
|
Phase 3 | |
Active, not recruiting |
NCT03675906 -
The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
|
||
Terminated |
NCT04071041 -
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
|
Phase 3 | |
Completed |
NCT03569410 -
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
|
N/A | |
Terminated |
NCT02457702 -
Mitochondrial Function in Patients With Severe Liver Disease
|
N/A | |
Completed |
NCT02765061 -
Hyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT03167645 -
SUbstition of PERioperative Albumin Deficiency Disorders
|
Phase 4 | |
Recruiting |
NCT05797649 -
Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis
|
||
Completed |
NCT01822600 -
The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
|
Phase 4 | |
Completed |
NCT01542749 -
Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer
|
N/A | |
Completed |
NCT00723762 -
Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients
|
N/A | |
Completed |
NCT00561093 -
Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
|
Phase 3 | |
Completed |
NCT04046263 -
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT00597025 -
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
|
N/A | |
Completed |
NCT06355479 -
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia
|
Phase 3 |